Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 4/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.33 |
| ▸ | PPARG | P37231 | 6/20 | 0.33 |
| ▸ | PPARD | Q03181 | 6/20 | 0.33 |
| ▸ | PPARA | Q07869 | 6/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.33 |
| ▸ | TLR2 | O60603 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | FABP4 | P15090 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3402335 | 1.00 | HDAC3 (0.50) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL28202809 | 0.81 | — | — | |
| SCHEMBL31065270 | 0.81 | — | — | |
| SCHEMBL11314784 | 0.78 | — | — | |
| SCHEMBL5698753 | 0.78 | — | — | |
| SCHEMBL6709788 | 0.73 | — | — | |
| SCHEMBL1563509 | 0.73 | HDAC3 (0.50) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL11131934 | 0.73 | HDAC3 (0.50) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL42275 | 0.73 | — | — | |
| SCHEMBL1022912 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030153483-A1 | Concentrated, stable fabric softening composition | TRINH TOAN (US) | 2003-08-14 | — | — | US | claimed |
| EP-0842250-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | claimed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| CN-101925554-B | Shrinkage reducing agent | CONSTR RES & TECH GMBH | 2014-06-18 | — | — | CN | disclosed |
| US-8353983-B2 | Shrinkage reducing agent | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-01-15 | — | — | US | disclosed |
| US-20120266782-A9 | Shrinking Reducing Agent | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2012-10-25 | — | — | US | disclosed |
| EP-2247552-B1 | SHRINKAGE REDUCING AGENT | CONSTR RES & TECH GMBH (DE) | 2012-07-11 | — | — | EP | disclosed |
| US-20120125236-A1 | Shrinking Reducing Agent | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2012-05-24 | — | — | US | disclosed |
| EP-2247552-A1 | SHRINKAGE REDUCING AGENT | Construction Research & Technology GmbH (DE) | 2010-11-10 | — | — | EP | disclosed |
| WO-2009095131-A1 | SHRINKAGE REDUCING AGENT | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120125236-A1 | Shrinking Reducing Agent | BCL2A1, CCAR2, C1R | HDAC3 1120/4885HDAC1 419/4885HDAC2 500/4885 |
| US-20120266782-A9 | Shrinking Reducing Agent | BCL2A1, CCAR2, C1R | HDAC3 1120/4885HDAC1 419/4885HDAC2 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.